Huang and colleagues [40] took a step further in taking DLBCL cell lines to gene expression profiling analysis and found an 11-gene STAT3 signature including CD48, IRF1 and IL10, which correlated well with inferior clinical outcomes. This evidence concerns the gene CD48 and diffuse large B-cell lymphoma.